| Literature DB >> 27292772 |
Nuor S M Jamil1, Asim Azfer1, Harrison Worrell1, Donald M Salter1.
Abstract
CSPG4/NG2 is a multifunctional transmembrane protein with limited distribution in adult tissues including articular cartilage. The purpose of this study was to investigate the possible roles of CSPG4/NG2 in chondrosarcomas and to establish whether this molecule may have potential for targeted therapy. Stable knock-down of CSPG4/NG2 in the JJ012 chondrosarcoma cell line by shRNA resulted in decreased cell proliferation and migration as well as a decrease in gene expression of the MMP (matrix metalloproteinase) 3 protease and ADAMTS4 (aggrecanase). Chondrosarcoma cells in which CSPG4/NG2 was knocked down were more sensitive to doxorubicin than wild-type cells. The results indicate that CSPG4/NG2 has roles in regulating chondrosarcoma cell function in relation to growth, spread and resistance to chemotherapy and that anti-CSPG4/NG2 therapies may have potential in the treatment of surgically unresectable chondrosarcoma.Entities:
Keywords: CSPG4; NG2; chondrosarcoma; therapy
Mesh:
Substances:
Year: 2016 PMID: 27292772 PMCID: PMC4926050 DOI: 10.1111/iep.12189
Source DB: PubMed Journal: Int J Exp Pathol ISSN: 0959-9673 Impact factor: 1.925